<DOC>
	<DOCNO>NCT01117662</DOCNO>
	<brief_summary>Acute kidney allograft rejection major cause loss graft function negative impact long-term graft survival . Anti-rejection therapy traditionally focus T cell-mediated mechanism renal allograft rejection . However , available agent affect T-cell pathway little impact long-term graft survival . There increase evidence B-cells play important role acute transplant rejection . CD20+ B cell infiltrate acute T-cell mediate rejection frequent correlate bad response conventional anti-rejection treatment increase risk graft loss . In one pilot study , support several case report , beneficial effect Rituximab treatment acute rejection episodes intrarenal B-cell infiltrates show . However , despite promise observation solid evidence require incorporating treatment option general treatment recommendation . In multicenter randomize placebo control double blind phase III trial investigator want demonstrate Rituximab addition standard treatment steroid-boli superior standard treatment alone regard long-term kidney function . If propose study prove Rituximab treatment acute rejection beneficial long-term allograft function , conventional rejection therapy need revise novel concept B- cell target</brief_summary>
	<brief_title>Efficacy Rituximab Acute Cellular Rejection Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Rituximab</mesh_term>
	<criteria>Inclusion criterion : 1. male female patient age ≥ 18 time inclusion study 2. male female patient kidney transplantation medically justifiable ( cave : previous immunosuppression , particularly prior induction therapy biologicals ) . 3 . Proof acute rejection kidney transplant accord Banffcriteria : Tcellmediated rejection borderline , grade IA/B , IIA/B ( vonly ) , one result available significant Bcell infiltrate CD20≥20 / high power field , glomerulitis , peritubular capillaritis C4d positivity ( exception ABOincompatible transplantation ) well patient Tcellmediated acute rejection , sign acute humoral rejection ( list accord criterion glomerulitis , peritubular capillaritis , C4d positivity ) treat accord medical opinion physician steroid therapy . The evidence rejection perform protocol indication biopsy . 4 . SV40negativity biopsy 5 . GFR calculate use MDRDFormula &gt; 25 ml/min/1,73 m² time period notice rejection . 6 . Presence negative pregnancy test consent highly effective contraceptive method ( i.e . failure rate le 1 % per year , implant , injectable contraceptive , combine oral contraceptive , intrauterine device ( hormone spiral ) , sexual abstinence vasectomy partner ) patient childbearing age . This required bilateral sterilization ovariectomy patient patient exclusively female sex partner . Presence consent highly effective contraceptive method male patient . 7 . Informed consent Exclusion criterion : 1 . Known contraindication , resp . incompatibility Rituximab and/or concomitant medication 2 . Administration Rituximab within last 12 month inclusion 3 . Simultaneous participation clinical study participation clinical study within last 30 day 4 . Breastfeeding woman pregnant woman 5 . Persons fail assess essence , mean significance clinical study act along line ( accord § 40 Abs . 4 § 41 Abs . 2 Abs . 3 AMG ) 6 . Existence active CMVinfection , existence HIVinfection , existence replicative hepatitis B C , existence grave infection 7 . Cardiac insufficiency phase NYHA IIIIV 8 . High grade cardiac arrhythmia 9 . Unstable coronary heart disease 10 . Poorly adjust diabetes mellitus ( HbA1c &gt; 10 % ) time inclusion study . 11 . State splenectomy 12 . Contraindication refer renew transplant biopsy ( e.g . coagulopathy , anticoagulation ) 13 . Other exclusion criterion accord estimate attending doctor ( e.g . aggravation general health condition , occurrence malignant disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>transplantation</keyword>
	<keyword>acute rejection</keyword>
	<keyword>kidney</keyword>
</DOC>